This process orchestrates the bidirectional regulation of tumor plasticity and the immunosuppressive microenvironment, providing a theoretical foundation for developing precision therapeutic strategies targeting the RBMX/TGF-β axis (64). Here, TGFB1 is linked to neoplasm.